Tuberculosis vaccines help prevention of tuberculosis by boosting a person's immune system to fight the bacteria. Bacille Calmette-Guérin (BCG) vaccine is the only licensed vaccine for tuberculosis currently in use globally. However, the research and development of new vaccines are constantly being done to improve protection and durability further. The global TB vaccine market growth is driven by the rising prevalence of tuberculosis disease globally. As per WHO estimates, about 10 million people fell ill with tuberculosis in 2021.

The Global tuberculosis vaccine market is estimated to be valued at US$ 172.42 Bn in 2024 and is expected to exhibit a CAGR of 21% over the forecast period from 2024 to 2030.

Key Takeaways

Key players operating in the tuberculosis vaccine market are Fujitsu Limited, Mindtree Limited, IBM Corporation, Wipro Limited, Unisys Corporation, CenturyLink Inc., Virtustream Inc. and HCL Technologies Limited.

The rising prevalence of tuberculosis worldwide is a key factor boosting the global Global Tuberculosis Vaccine Market Size. As per WHO data, in 2021, there were an estimated 10.0 million new TB cases worldwide, a 4.5% reduction from the number of new TB cases in 2020. Furthermore, tuberculosis is the thirteenth leading cause of death worldwide and the second leading infectious cause of death after COVID-19. Thus, increasing cases worldwide will drive vaccine demand.

Major technological developments are ongoing in the tuberculosis vaccine space. Companies are focused on developing new vaccines with improved features and better efficacy and durability against the disease. For example, vaccines based on mRNA technology, viral vectors are being developed and tested which can induce better immune response.

Market Trends

Personalized Vaccines - Researchers are exploring options to develop personalized tuberculosis vaccines specific for each individual based on their immune responses, genotypes, and risk factors. This could help enhance protective efficacy of vaccines.

Novel vaccine platforms - Novel vaccine platforms such as mRNA vaccines, viral vectored vaccines, protein subunit vaccines are being explored with promising results in preclinical and clinical trials. If approved, they can help address current limitations with BCG vaccine.

Market Opportunities

Emerging markets - Despite declines in incidence, tuberculosis remains a major challenge in developing nations. Thus emerging countries in Africa, Asia, and Latin America present significant market opportunities for novel tuberculosis vaccines

Booster dose - Given evolving immunity against TB over time, booster doses of TB vaccines are being explored as a strategy to maintain long term protection. This presents an opportunity for higher uptake.

In conclusion, the tuberculosis vaccine market is poised to grow substantially given rising disease burden worldwide and ongoing research on novel technologies and vaccine types with greater efficacy. The market is also expected to benefit from initiatives to boost access to vaccines in high burden low-income countries.

Impact of COVID-19 on Tuberculosis Vaccine Market Growth

The COVID-19 pandemic has significantly impacted the growth of the tuberculosis vaccine market. During the initial outbreak phase, many research and development activities were halted due to lockdowns imposed across various countries. This led to delays in new vaccine development programs. Existing production and supply chains were also disrupted due to restrictions on trade and travel. However, with lockdowns being gradually lifted, manufacturers are resuming their operations while ensuring necessary safety protocols. Government and private organizations have ramped up funding for TB vaccine development programs, recognizing the need to boost prevention efforts against opportunistic infections amid the ongoing health crisis. Researchers are also investigating the role of potential cross-reactivity between SARS-CoV-2 and TB vaccines to understand if existing Bacillus Calmette-Guérin (BCG) vaccines provide additional protection against COVID-19 infection. Overall, while the pandemic posed initial challenges for market players, focus on TB prevention is increasing in the long run to tackle infectious disease burdens.

Value Concentration in Tuberalosis Vaccine Market

In terms of value, North America holds the leading share in the tuberculosis vaccine market currently. This is mainly attributed to growing incidence of drug-resistant TB cases and presence of major vaccine manufacturers in the region. Furthermore, rising healthcare investments and stringent regulatory guidelines support clinical trials and new product approvals. Asia Pacific is also among the high value regions due to the huge patient population and improving access to advanced treatment options, especially in emerging economies like India, China and Japan. Governments are collaborating with international organizations to strengthen prevention programs, while medical tourism continues to drive the regional market. Meanwhile, other regions such as Latin America and Middle East & Africa are showing fast growth due to increasing awareness about availability of novel TB vaccines and expanding healthcare infrastructure.

Fastest Growing Region in Tuberculosis Vaccine Market

Europe accounts for the fastest market growth and is expected to maintain this momentum over the forecast period. This can be accredited to growing elderly population susceptible to TB infection, alongside higher adoption of state-of-the-art immunization therapies. In addition, presence of leading biopharmaceutical companies conducting extensive R&D expedites product commercialization. Favorable reimbursement scenarios further boost vaccination rates across various countries. Alongside Europe, substantial market potential exists in developing areas including Sub-Saharan Africa due to rising incidence of Multi Drug Resistant (MDR) tuberculosis and government initiatives around disease control programs. However, lack of proper diagnosis and treatment challenges market expansion to some extent in these regions.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/tuberculosis-vaccine-market-forecast-outlook-trend-2023-2030/